Takako Inoue

Statistics

Publications

Citations

582

H-Index

Active since

1983

Affiliations

Osaka International Cancer Institute(Current)

National Taiwan University Hospital

Shanghai Chest Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

First Affiliated Hospital Zhejiang University

Takako Inoue is an author at Osaka International Cancer Institute specializing in targeted therapy, medicine, and epidermal growth factor receptor inhibition.

ORCID

Publications per year

1983–2024

Publications

Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC

Shun Lu, Terufumi Kato, Xiaorong Dong et al. · New England Journal of Medicine · 2024 · 295 citations

Medicine, Oncology, Pharmacology +15

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

Pemetrexed and platinum with or without pembrolizumab for tyrosine kinase inhibitor (TKI)-resistant, EGFR -mutant, metastatic nonsquamous NSCLC: Phase 3 KEYNOTE-789 study.

James Chih‐Hsin Yang, Dae Ho Lee, Jong Seok Lee et al. · Journal of Clinical Oncology · 2023 · 94 citations

Medicine, Oncology, Pharmacology +16

Analysis of Impurities in Methamphetamine

Tohru Kishi, Takako Inoue, SHINICHI SUZUKI et al. · Eisei kagaku · 1983 · 27 citations · Full text

Pharmacy, Chemistry, Pharmaceutical Analysis +16

Analysis of Methamphetamine in Human Hair by Mass Fragmentography

SHINICHI SUZUKI, Takako Inoue, TOSHIHIRO YASUDA et al. · Eisei kagaku · 1984 · 12 citations · Full text

Pharmacy, Toxicology, Analytical Toxicology +13

1–5 of 6